Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial

被引：0
|
作者：
Xiao-Bing Yang
Wan-yin Wu
Shun-qin Long
Hong Deng
Zong-Qi Pan
Wen-Feng He
Yu-Shu Zhou
Gui-Ya Liao
Qiu-Ping Li
Shu-Jing Xiao
Jiao-Zhi Cai
机构：
[1] Guangdong Provincial Hospital of Traditional Chinese Medicine,Department of Oncology
来源：
Trials | / 16卷
关键词：
Non-small cell lung cancer; Chinese herbal medicine; decoction; Gefitinib; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Chia-Chi Lin
    James Chih-Hsin Yang
    Drugs, 2011, 71 : 79 - 88
  • [32] Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    DRUGS, 2011, 71 (01) : 79 - 88
  • [33] Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients
    Stoyan Naidenov Bichev
    Dora Marinova Marinova
    Yanina Georgieva Slavova
    Alexey Slavkov Savov
    Cellular Oncology, 2015, 38 : 145 - 153
  • [34] Epidermal growth factor receptor mutations in Chinese patients with non-small cell lung cancer.
    Zhou, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 645S - 645S
  • [35] Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients
    Bichev, Stoyan Naidenov
    Marinova, Dora
    Slavova, Yanina Georgieva
    Savov, Alexey Slavkov
    CELLULAR ONCOLOGY, 2015, 38 (02) : 145 - 153
  • [36] Efficacy of Gefitinib in Patients With Epidermal Growth Factor Receptor Mutation Positive Advanced Non-Small-Cell Lung Cancer - a Metaanalysis of Randomized Controlled Trials
    Aydiner, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S630 - S630
  • [37] Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib
    David F. Heigener
    Martin Reck
    Advances in Therapy, 2011, 28 : 126 - 133
  • [38] Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib
    Heigener, David F.
    Reck, Martin
    ADVANCES IN THERAPY, 2011, 28 (02) : 126 - 133
  • [39] Epidermal growth factor receptor mutations in unselected advanced non-small cell lung cancers in Thai patients
    Charoentum, C.
    Lertprasertsuke, N.
    Phanthunane, C.
    Theerakittikul, T.
    Liwsrisakun, C.
    Saeteng, S.
    Tantraworasin, A.
    Suksombooncharoen, T.
    Chewaskulyong, B.
    Thongprasert, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S610 - S610
  • [40] Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations
    Yoshida, Kimihide
    Yatabe, Yasushi
    Park, Jangchul
    Ogawa, Shizu
    Park, Ji Young
    Shimizu, Junichi
    Horio, Yoshitsugu
    Matsuo, Keitaro
    Mitsudomi, Tetsuya
    Hida, Toyoaki
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (04) : 527 - 535
12345